Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
The Annals of Pharmacotherapy|November 20, 2008
Successful treatment of fosinopril-induced severe cholestatic jaundice with plasma exchangeJen-Wei Chou, Cheng-Ju Yu, Po-Heng Chuang, et al.
Hepatitis Monthly|April 3, 2015
An index to predict ribavirin-induced anemia in asian patients with chronic genotype 1 hepatitis CSheng-Hung Chen, Cheng-Yuan Peng, Hsueh-Chou Lai, et al.
Plos One|December 31, 2020
Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenibMing-Han Hsieh, Tzu-Yu Kao, Ting-Hui Hsieh, et al.
Therapeutic Advances in Chronic Disease|January 24, 2022
Long-term surveillance of liver histological changes in chronic hepatitis C patients completing pegylated interferon-α plus ribavirin therapy: an observational cohort studyMing-Han Hsieh, Tzu-Yu Kao, Ting-Hui Hsieh, et al.
Scientific Reports|July 2, 2017
Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytesJu-Chien Cheng, Ching-Ping Tseng, Mei-Huei Liao, et al.
Plos One|October 14, 2015
Head-to-Head Comparison between Collagen Proportionate Area and Acoustic Radiation Force Impulse Elastography in Liver Fibrosis Quantification in Chronic Hepatitis CSheng-Hung Chen, Cheng-Yuan Peng, Hsueh-Chou Lai, et al.
Journal of Viral Hepatitis|June 3, 2022
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver-related complications in patients with chronic hepatitis C receiving direct-acting antiviral agentsWei-Fan Hsu, Hsueh-Chou Lai, Po-Heng Chuang, et al.
Medicine|August 24, 2017
Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer?: Evidence from a nationwide cohort studyChia-Sheng Chu, Che-Chen Lin, Cheng-Yuan Peng, et al.
Cancer Cell International|June 21, 2025
HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progressionYang-Hsiang Lin, Ming-Wei Lai, Yu-De Chu, et al.
Cancers|August 7, 2021
On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular CarcinomaHung-Wei Wang, Po-Heng Chuang, Wen-Pang Su, et al.
Pageof 5